Skip to content
healthcare.dev

Olopatadine hydrochloride

NDC 60505-6222, Olopatadine hydrochloride, solution/ drops, from Apotex Corp..

Product NDC
60505-6222
Status
Listed
Labeler
Apotex Corp.
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA090918
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6222 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLOPATADINE HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]

Package NDCNDC-11Package
60505-6222-2605056222021 BOTTLE, PLASTIC in 1 CARTON (60505-6222-2) / 2.5 mL in 1 BOTTLE, PLASTIC (60505-6222-1)
60505-6222-3605056222032 BOTTLE, PLASTIC in 1 CARTON (60505-6222-3) / 2.5 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 60505-6222 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6222 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-6222. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.